Wednesday, September 9, 2026

At Least 48 Taken to Hospitals Over Suspicions of Anthrax Outbreak in Turkey

Cagri Akyurt

September 10, 2018

A cow of Turkish Natıve Black Cattle breed. Photo by: Zeynel Cebeci.
ANKARA, Turkey (ViaNews) - According to the reports from the ministry of health, some cities in the southeast of the country and a facility in Istanbul has been quarantined following the increase of anthrax patients. Fahrettin Koca, Minister of Health told in a written statement: “48 people, who were in contact with cattle suspected to be infected by anthrax were sent to our facilities for examination. Six of these people were confirmed to develop skin lesions, which is a symptom of anthrax infection.” According to the Minister of Forestry and Agriculture, two neighbourhoods of Istanbul’s Silivri district were quarantined and more than 3000 animals were vaccinated as a precaution. There were similar reports from Ankara and Sivas as well. Authorities detected that cattle imported from Brazil to Meat and Milk Institution were infected with anthrax. After the sudden death of more than 140 animals on a farm in Ankara, authorities detected signs of anthrax, leading them to kill the animals and keep the farm under quarantine. A few days later a family of three from Sivas was hospitalized for anthrax suspicion after eating an infected animal. According to Demirören News Agency, the family butchered their animal after its sudden death, before they recognized the symptoms. While the daughter and the father are discharged from the hospital, the son is still being kept in quarantine.

Categories

Tags

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Investment Boom Meets Market Skepticism: Palantir's Contract Win vs. Stock Slide Amid Record Private AI Funding
Palantir secured the Army's high-profile TITAN AI-sensing contract and added a new executive, yet its stock fell 6% the same day — a sign that even marquee government AI wins no longer guarantee investor confidence. This tension plays out against a backdrop of surging private capital flooding into AI and AI-adjacent companies (Stability AI, Socure, Generalist AI, Emerald AI, and others), showing a bifurcated market: venture funding for AI remains red-hot while public-market sentiment toward AI-defense/enterprise plays is growing more cautious.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
General Motors Company
Both facts reference General Motors' cash position at the identical point in time (2025-12-31), both measuring FY 2025 period-end. Fact A reports $20.945 billion while Fact B reports $21.7 billion—a $755 million discrepancy (3.6% difference). Since they share the same entity, attribute, date, and fiscal period with conflicting values, this is a genuine contradiction, not a change over time. The difference is material enough to suggest either: different source data, different cash classifications (e.g., one includes equivalents/restricted cash), preliminary vs. final figures, or a data quality issue.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,278 source documents archived
Query this data → isubstrate.com